Morgan Stanley analyst Terence Flynn reiterated an Overweight rating and $123.00 price target on Gilead Sciences (NASDAQ: GILD)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE